Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 2,577,333 | 2,577,333 | 0 | $482.68M | $529.02M | 23.04% | +$46.34M |
| Relay Therapeutics, Inc.(RLAY) | 16,035,240 | 16,035,240 | 0 | $300.02M | $289.44M | 12.61% | -$10.58M |
| GeneDx Holdings Corp.CL A(WGS) | 3,707,164 | 3,707,164 | 0 | $254.50M | $268.03M | 11.68% | +$13.53M |
| Biolife Solutions Inc | 4,655,000 | 4,500,000 | -155,000 | $131.46M | $174.82M | 7.62% | +$43.37M |
| Illumina, Inc.(ILMN) | 530,000 | 530,000 | 0 | $93.19M | $145.05M | 6.32% | +$51.86M |
| GRAIL, Inc.(GRAL) | 480,000 | 680,000 | +200,000 | $32.77M | $95.28M | 4.15% | +$62.51M |
| 10x Genomics, Inc.CL A(TXG) | 1,050,000 | 1,050,000 | 0 | $40.26M | $94.88M | 4.13% | +$54.62M |
| Standard Biotools Inc | 88,783,856 | 88,783,856 | 0 | $73.04M | $65.75M | 2.86% | -$7.29M |
| Neurogene Inc | 1,545,361 | 1,585,361 | +40,000 | $48.60M | $44.10M | 1.92% | -$4.50M |
| Scholar Rock Holding Corporation(SRRK) | 665,000 | 850,000 | +185,000 | $36.58M | $41.07M | 1.79% | +$4.50M |
| Personalis, Inc.(PSNL) | 2,550,000 | 2,300,000 | -250,000 | $34.17M | $37.44M | 1.63% | +$3.27M |
| Beam Therapeutics Inc.(BEAM) | 1,350,000 | 1,500,000 | +150,000 | $46.33M | $36.67M | 1.60% | -$9.66M |
| Tempus AI, Inc.CL A(TEM) | 0 | 423,597 | +423,597 | $0 | $34.69M | 1.51% | +$34.69M |
| Sarepta Therapeutics, Inc.(SRPT) | 470,000 | 1,820,000 | +1,350,000 | $8.45M | $33.16M | 1.44% | +$24.71M |
| Guardant Health, Inc.(GH) | 185,000 | 185,000 | 0 | $27.76M | $33.00M | 1.44% | +$5.24M |
| Structure Therapeutics IncADS | 1,175,000 | 1,030,000 | -145,000 | $63.06M | $32.21M | 1.40% | -$30.85M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 75,000 | 120,000 | +45,000 | $22.58M | $29.61M | 1.29% | +$7.03M |
| Denali Therapeutics Inc.(DNLI) | 2,045,000 | 1,250,000 | -795,000 | $52.60M | $25.84M | 1.13% | -$26.76M |
| Hims & Hers Health, Inc.CL A(HIMS) | 700,000 | 800,000 | +100,000 | $24.27M | $23.83M | 1.04% | -$437.0K |
| Maze Therapeutics, Inc.(MAZE) | 843,857 | 843,857 | 0 | $25.18M | $22.94M | 1.00% | -$2.24M |
| Septerna, Inc.(SEPN) | 553,268 | 553,268 | 0 | $18.53M | $21.65M | 0.94% | +$3.12M |
| Parabilis Medicines Inc | 645,690 | 645,690 | 0 | $17.67M | $20.85M | 0.91% | +$3.18M |
| Adlai Nortye Group LtdADS | 1,250,000 | 1,250,000 | 0 | $14.38M | $20.00M | 0.87% | +$5.63M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,250,000 | 3,900,000 | +650,000 | $22.13M | $18.99M | 0.83% | -$3.14M |
| Agomab Therapeutics NvADS | 1,550,000 | 1,550,000 | 0 | $20.12M | $17.20M | 0.75% | -$2.91M |
| Oric Pharmaceuticals Inc | 0 | 1,250,000 | +1,250,000 | $0 | $16.84M | 0.73% | +$16.84M |
| Moderna, Inc.(MRNA) | 75,000 | 75,000 | 0 | $5.25M | $14.44M | 0.63% | +$9.19M |
| Veracyte, Inc.(VCYT) | 276,308 | 276,308 | 0 | $16.23M | $12.72M | 0.55% | -$3.51M |
| Quest Diagnostics Incorporated(DGX) | 50,000 | 50,000 | 0 | $10.60M | $11.65M | 0.51% | +$1.06M |
| Biogen Inc.(BIIB) | 0 | 50,000 | +50,000 | $0 | $11.29M | 0.49% | +$11.29M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 265,000 | +265,000 | $0 | $10.76M | 0.47% | +$10.76M |
| Absci Corporation | 973,260 | 973,260 | 0 | $11.28M | $10.48M | 0.46% | -$798.1K |
| Prime Medicine, Inc.(PRME) | 3,167,175 | 3,167,175 | 0 | $11.69M | $9.68M | 0.42% | -$2.01M |
| BioNTech SEADS(BNTX) | 0 | 85,000 | +85,000 | $0 | $8.36M | 0.36% | +$8.36M |
| Braveheart Bio Inc | 0 | 400,000 | +400,000 | $0 | $8.08M | 0.35% | +$8.08M |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 200,000 | +200,000 | $0 | $6.72M | 0.29% | +$6.72M |
| Intellia Therapeutics, Inc.(NTLA) | 355,000 | 355,000 | 0 | $6.01M | $4.28M | 0.19% | -$1.73M |
| uniQure N.V.SHS(QURE) | 150,000 | 150,000 | 0 | $6.91M | $3.62M | 0.16% | -$3.29M |
| Century Therapeutics Inc | 1,228,190 | 1,228,190 | 0 | $3.01M | $2.10M | 0.09% | -$908.9K |
| Contineum Therapeutics IncCL A | 148,333 | 148,333 | 0 | $2.43M | $1.99M | 0.09% | -$440.5K |
| Pacific Biosciences Calif In | 723,767 | 723,767 | 0 | $1.22M | $1.72M | 0.07% | +$499.4K |
| Bridgebio Oncology Therapeut | 282,312 | 282,312 | 0 | $2.15M | $1.16M | 0.05% | -$993.7K |
| Editas Medicine Inc | 445,000 | 445,000 | 0 | $1.44M | $1.14M | 0.05% | -$298.1K |
| Monte Rosa Therapeutics Inc | 186,014 | 86,014 | -100,000 | $4.50M | $1.03M | 0.04% | -$3.48M |
| Kardigan Inc | 50,000 | 50,000 | 0 | $1.19M | $737.5K | 0.03% | -$455.0K |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 165,323 | 165,323 | 0 | $606.7K | $682.8K | 0.03% | +$76.0K |
| Ginkgo Bioworks Holdings IncCL A | 36,493 | 36,493 | 0 | $361.6K | $468.2K | 0.02% | +$106.6K |
| Tenaya Therapeutics Inc | 361,969 | 361,969 | 0 | $267.5K | $218.5K | 0.01% | -$49.0K |
| Disc Medicine, Inc.(IRON) | 65,000 | 0 | -65,000 | $4.75M | $0 | — | -$4.75M |
| Sionna Therapeutics, Inc.(SION) | 400,000 | 0 | -400,000 | $17.60M | $0 | — | -$17.60M |